Opinion
Video
Treatment Flexibility While on Abrocitinib in Atopic Dermatitis (JADE REGIMEN)
Author(s):
Key Takeaways
- Oral JAK inhibitors provide a convenient alternative to injectable biologics, potentially enhancing patient adherence in maintenance therapy.
- These inhibitors target specific inflammatory pathways, offering a tailored approach to managing autoimmune conditions.
Medical experts review the data on the use of oral JAK inhibitors for maintenance and rescue treatments in atopic dermatitis.
EP: 1.JAK Inhibitors and Pathophysiology of Atopic Dermatitis
EP: 2.Oral JAK inhibitors and Their Use for Treatment of Atopic Dermatitis
EP: 3.Oral JAK Inhibitor Use in Atopic Dermatitis: Screening and Monitoring Patients
EP: 4.Long-term Safety Data for JAK Inhibitors in Atopic Dermatitis
EP: 5.Utilizing Long-Term Atopic Dermatitis Data in Clinical Practice
EP: 6.Data on Early Itch Relief with JAK Inhibitors in Atopic Dermatitis
EP: 7.Speed of Itch Relief in Atopic Dermatitis
EP: 8.Systemic Treatments and Switching Therapy in Atopic Dermatitis
EP: 9.Treatment Expectations and Patient Conversations in Atopic Dermatitis
EP: 10.Switching from Biologics to JAK Inhibitors in Atopic Dermatitis: Clinical Data
EP: 11.Treatment Breaks and Rescue Treatments in Atopic Dermatitis
EP: 12.Switching patients to JAK Inhibitors in Atopic Dermatitis in Clinical Practice
Now Viewing
EP: 13.Treatment Flexibility While on Abrocitinib in Atopic Dermatitis (JADE REGIMEN)
EP: 14.Future Outlook for Atopic Dermatitis Treatments
Video content above is prompted by the following:
Please discuss data with oral JAK inhibitors as maintenance and rescue treatments.
Related Videos
Related Content
